Terrie Curran - 19 Jan 2022 Form 4/A - Amendment Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: President and Chief Executive, Director
Signature: /s/ Larry Miller, Attorney-in-Fact for Terrie Curran
Issuer symbol: PHAT
Transactions as of: 19 Jan 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 11 Mar 2022, 16:18:30 UTC
Date Of Original Report: 21 Jan 2022
Previous filing: 09 Nov 2021
Next filing: 16 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PHAT	Common Stock						42,955	19 Jan 2022	Direct	F1
holding	PHAT	Common Stock						724	19 Jan 2022	by 401(k)	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 21, 2022, the Reporting Person filed a Form 4 (the "Original Form 4") which inadvertently reported incorrect amounts of securities beneficially owned following the transactions reported. Following the transactions reported in the Original Form 4, the Reporting Person (i) directly owns 42,955 shares of Common Stock, which includes 41,250 restricted stock units, and (ii) indirectly owns 724.10 shares of Common Stock through a 401(k) account.

Content

On January 21, 2022, the Reporting Person filed a Form 4 (the "Original Form 4") which inadvertently reported incorrect amounts of securities beneficially owned following the transactions reported. Following the transactions reported in the Original Form 4, the Reporting Person (i) directly owns 42,955 shares of Common Stock, which includes 41,250 restricted stock units, and (ii) indirectly owns 724.10 shares of Common Stock through a 401(k) account.